(S (NP (NP (DT The) (NN campaign)) (PP (IN against) (NP (NN drug) (NN abuse)))) (VP (VBZ is) (VP (VBN fought) (PP (IN by) (NP (DT all) (NNS countries))) (, ,) (ADVP (JJS most) (RB notably)) (PP (IN on) (NP (NNP ATS) (NNS drugs))))) (. .))
(S (NP (NP (DT The) (JJ technical) (NNS limitations)) (PP (IN of) (NP (DT the) (JJ current) (NN test) (NNS kits))) (SBAR (S (VP (TO to) (VP (VB detect) (NP (NP (JJ new) (NN brand)) (PP (IN of) (NP (NNP ATS) (NNS drugs))))))))) (VP (VBD present) (NP (DT a) (NN challenge)) (PP (TO to) (NP (NP (NN law) (NN enforcement) (NNS authorities)) (CC and) (NP (JJ forensic) (NNS laboratories))))) (. .))
(S (ADVP (RB Meanwhile)) (, ,) (S (NP (NP (JJ new) (JJ molecular) (NN imaging) (NNS devices)) (SBAR (WHNP (WDT which)) (S (VP (VBD allowed) (S (NP (NNS mankind)) (VP (TO to) (VP (VB characterize) (NP (DT the) (JJ physical) (CD 3D) (JJ molecular) (NN structure))))))))) (VP (VBP have) (VP (VBN been) (ADVP (RB recently)) (VP (VBN introduced))))) (, ,) (CC and) (S (NP (PRP it)) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB remedy) (NP (NP (DT the) (NNS limitations)) (PP (IN of) (NP (VBG existing) (NN drug) (NN test) (NNS kits))))))))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP (NP (DT a) (JJ new) (NN type)) (PP (IN of) (NP (CD 3D) (JJ molecular) (NN structure) (NN representation) (NN technique)))) (VP (MD should) (VP (VB be) (VP (VBN developed) (S (VP (TO to) (VP (VB cater) (NP (NP (DT the) (CD 3D) (JJ molecular) (NN structure)) (VP (VBD acquired) (S (VP (ADVP (RB physically)) (VBG using) (NP (DT these) (JJ molecular) (NN imaging) (NNS devices)))))))))))) (. .))
(S (S (NP (NP (CD One)) (PP (IN of) (NP (NP (DT the) (NNS applications)) (PP (IN of) (NP (NN image) (NN processing) (NNS methods))) (SBAR (S (VP (TO to) (VP (VB represent) (NP (DT a) (CD 3D) (NN image))))))))) (VP (VBZ is) (NP (CD 3D) (NNS moments)))) (, ,) (CC and) (S (NP (DT this) (NN study)) (VP (VBZ formulates) (NP (NP (DT a) (JJ new) (CD 3D) (NNS moments) (NN technique)) (, ,) (ADVP (RB namely)) (NP (CD 3D) (NNP Hahn) (NNS moments)) (, ,) (SBAR (S (VP (TO to) (VP (VB represent) (NP (NP (DT the) (CD 3D) (JJ molecular) (NN structure)) (PP (IN of) (NP (NNP ATS) (NNS drugs))))))))))) (. .))
(S (NP (NP (DT The) (NN performance)) (PP (IN of) (NP (DT the) (VBN proposed) (NN technique)))) (VP (VBD was) (VP (VBN analysed) (S (VP (VBG using) (NP (NP (NN drug) (NN chemical) (NNS structures)) (VP (VBN obtained) (PP (IN from) (NP (NNP UNODC))) (PP (IN for) (NP (DT the) (NNP ATS) (NNS drugs))))))) (, ,) (SBAR (IN while) (S (NP (JJ non-ATS) (NNS drugs)) (VP (VBP are) (VP (VBN obtained) (ADVP (RB randomly)) (PP (IN from) (NP (NNP ChemSpider) (NN database))))))))) (. .))
(S (NP (DT The) (NN evaluation)) (VP (VBZ shows) (SBAR (S (NP (DT the) (NN technique)) (VP (VBZ is) (VP (VBN qualified) (S (VP (TO to) (VP (VB be) (VP (ADVP (RB further)) (VBN explored) (PP (IN in) (NP (DT the) (NN future) (VBZ works))) (S (VP (TO to) (VP (VB be) (ADJP (RB fully) (JJ compatible) (PP (IN with) (NP (NNP ATS) (NN drug) (NN identification) (NN domain)))))))))))))))) (. .))
